Abstract: Ten percent of the population will develop plantar
fasciitis (PF) during their lifetime. Two million people are treated
yearly accounting for 11-15% of visits to medical professionals.
Treatment ranges from conservative to surgical intervention. The
purpose of this study was to assess the effects of extracorporeal
shockwave therapy (ECSWT) on heel pain, function, range of motion
(ROM), and strength in patients with PF. One hundred subjects were
treated with ECSWT and measures were taken before and three
months after treatment. There was significant differences in visual
analog scale scores for pain at rest (p=0.0001); after activity (p=
0.0001) and; overall improvement (p=0.0001). There was also
significant improvement in Lower Extremity Functional Scale scores
(p=0.0001); ankle plantarflexion (p=0.0001), dorsiflexion (p=0.001),
and eversion (p=0.017),and first metatarsophalangeal joint flexion
(p=0.002) and extension (p=0.003) ROM. ECSWT is an effective
treatment improving heel pain, function and ROM in patients with
PF.
Abstract: Increased physical fitness participation has been
paralleled by increasedoveruse injuries such as insertional Achilles
tendinosis (AT). Treatment has provided inconsistentresults. The use
of extracorporeal shockwave therapy (ECSWT) offers a new
treatment consideration.The purpose of this study was to assess the
effects of ECSWTon pain, function, range of motion (ROM), joint
mobility and strength in patients with AT. Thirty subjects were
treated with ECSWT and measures were takenbefore and three
months after treatment. There was significant differences in visual
analog scale (VAS) scores for pain at rest (p=0.002); after activity
(p= 0.0001); overall improvement(p=0.0001); Lower Extremity
Functional Scale (LEFS) scores (p=0.002); dorsiflexion range of
motion (ROM) (p=0.0001); plantarflexion strength (p=0.025);
talocrural joint anterior glide (p=0.046); and subtalar joint medial and
lateral glide (p=0.025).ECSWT offers a new intervention that may
limit the progression of the disorder and the long term healthcare
costs associated with AT.